Acquisition Watch: Time to Buy Johnson & Johnson (JNJ) or ShockWave Medical's (SWAV) Stock?

News of healthcare behemoth Johnson & Johnson (JNJ)  acquiring medical device company ShockWave Medical (SWAV)  made headlines this morning. The acquisition is expected to be completed later this year and is valued at $13.1 billion or$335 a share and 3% above ShockWave's current stock price. ShockWave’s stock is up 2% in Friday’s trading session with Johnson & Johnson shares virtually flat and trading at $152 a share. With that being said, let’s see if it’s a good time to buy stock in either of these healt ...